NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus

  • US 5,714,596 A
  • Filed: 03/31/1993
  • Issued: 02/03/1998
  • Est. Priority Date: 11/18/1987
  • Status: Expired due to Term
First Claim
Patent Images

1. A purified preparation of an oligonucleotide, wherein the oligonucleotide is capable of selectively hybridizing to the genome of a hepatitis C virus (HCV), or its complement, relative to other viral agents, and further wherein the oligonucleotide comprises a contiguous sequence of at least 10 nucleotides fully complementary to either strand of the nucleotide residue sequence depicted in FIG. 1.

View all claims

    Thank you for your feedback